Stivarga (regorafenib)

pCPA File Number: 21040
Negotiation Status:
Concluded with an LOI
Indication(s):
Unresectable Hepatocellular Carcinoma
Sponsor/Manufacturer:
Bayer Inc.
CDA-AMC Project Number:
PC0119-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: